Table 4.
Patient number | Ig route | IgG trough level (g/dl)a | Lung diseaseb | Prophylactic antibiotics | Co-morbidities | |
---|---|---|---|---|---|---|
CT | Lung function | |||||
1 | IV | 7.4 | Not done | Not done | None | Gastro-esophageal reflux |
2 | SC | 7.1 | Normal | Not done | None | Eczema |
3 | SC | 8.7 | Progression | Stable—obstructive | None | |
4 | IV | 11.7 | Stable disease | Stable—obstructive | Azithromycin 3×/week | |
5 | SC | 7.6 | Stable disease | Stable—obstructive | None | |
6 | SC | 7.9 | Normal | Stable—normal | None | |
7 | SC | 5.8 | Progression | Stable—restrictive | None | |
8 | SC | 1.6 | Stable disease | Deterioration—obstructive | None | |
9 | IV | 6.9 | Normal | Stable—normal | None | Deafness |
10 | SC | 9.0 | Normal | Stable—normal | None | |
11 | IV | 7.6 | Normal | Stable—normal | None | |
12 | SC | 9.5 | Normal | Stable—normal | Azithromycin 3×/week | |
13 | IV | 11.5 | Progression (pre-transplant) | Deterioration—obstructive (pre-transplant) |
Co-trimoxazole daily | Lung transplant |
14 | IV | 10.0 | Progression | Stable—normal | None | |
15 | IV | 15.3 | Progression | Not done | None | Autism, epilepsy |
aMean over the last 5 years
bFrom the previous 5 years